U.S. proposed coverage decision for transcatheter aortic-valve replacement with broader eligibility

 

U.S. government issues proposed coverage decision for transcatheter aortic-valve replacement with broader eligibility, reduced procedural requirements

• Edwards Lifesciences was the stock referenced alongside the U.S. government's proposed coverage decision for transcatheter aortic-valve replacement in the report.

https://finviz.com/stock?t=EW&p=d